Latest Developments in North America Infusion Pumps Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in North America Infusion Pumps Market

  • Healthcare
  • May 2025
  • North America
  • 150 Pages
  • No of Tables: 30
  • No of Figures: 50

  • In November 2024, ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. entered into a strategic joint venture aimed at bolstering supply chain resilience and driving innovation in the North American intravenous (IV) solutions market. This collaboration combines Otsuka’s vast global manufacturing expertise with ICU Medical’s robust production and distribution network across North America. Together, the two companies plan to provide cutting-edge IV pumps and consumables to healthcare providers, ensuring more reliable and efficient healthcare delivery
  • In January 2024, Lemer Pax, a global leader in radiation protection technologies, entered into a partnership with ICU Medical, a renowned provider of infusion systems, to distribute the Plum 360 infusion pump in the French nuclear medicine sector. This collaboration is part of ICU Medical’s strategy to expand its footprint in the European market. The partnership aims to enhance the efficiency and safety of nuclear medicine treatments, positioning ICU Medical's Plum 360 as a key tool in the delivery of precise medication administration in specialized medical settings across Europe
  • In October 2024, the South Korea infusion pumps market is projected to experience robust growth, with an estimated CAGR of 7.9% from 2024 to 2034. This growth is driven by increasing demand for advanced medical technologies, the rising prevalence of chronic diseases, and expanding healthcare infrastructure. The market is also benefitting from the growing adoption of smart infusion pumps in hospitals and homecare settings
  • ​In August 2024, the North America infusion devices market was valued at approximately US$ 5.49 billion and is projected to reach US$ 9.12 billion by 2031, reflecting a 6.5% CAGR during the forecast period. This growth is driven by the increasing prevalence of chronic diseases such as cancer and diabetes, a rising geriatric population, and advancements in infusion device technologies. Notably, the infusion pumps segment is expected to lead the market, with innovations like Baxter's Novum IQ large volume infusion pump and BD's Alaris Infusion System enhancing safety and efficiency in clinical settings